BOC Report and accounts 2005 - Alle jaarverslagen
BOC Report and accounts 2005 - Alle jaarverslagen
BOC Report and accounts 2005 - Alle jaarverslagen
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Notes to the financial statements 97<br />
2. Profit <strong>and</strong> loss continued<br />
b) Exceptional items analysis<br />
<strong>2005</strong> 2004 2003<br />
£ million £ million £ million<br />
Charged in arriving at operating profit<br />
Restructuring costs (6.8) (17.4) (23.8)<br />
Impairment of goodwill (13.9) – –<br />
Litigation settlement – – (43.2)<br />
Total operating exceptional items (20.7) (17.4) (67.0)<br />
i) Restructuring costs <strong>and</strong> impairment of goodwill<br />
£20.7 million has been charged in <strong>2005</strong> for restructuring in <strong>BOC</strong> Edwards.This comprises goodwill impairment of £13.9 million <strong>and</strong> severance costs.Savings of<br />
approximately £5 million are targeted from this restructuring during 2006.<br />
In 2004 following the sale of the packaged gas business in the US, costs of £14.8 million were incurred to restructure the footprint of the remaining<br />
business in the US.This covered the severance costs <strong>and</strong> other costs of restructuring those functions which are shared by <strong>BOC</strong>’s businesses in the US.<br />
Restructuring costs in 2004 also included a charge of £2.6 million (2003: £8.3 million) relating to the integration of <strong>BOC</strong>’s gases business <strong>and</strong> part of the<br />
Air Liquide business in Japan to form Japan Air Gases.<br />
The restructuring costs in 2003 related to various programmes including programmes under the business initiative announced in August 2001.<br />
The major programmes covered investments in information management systems, the restructuring of <strong>BOC</strong> Edwards’ manufacturing capacity <strong>and</strong><br />
restructuring to deliver operational efficiencies in Process Gas Solutions <strong>and</strong> Industrial <strong>and</strong> Special Products.These programmes were completed in 2004.<br />
Cash flow from operating activities includes an outflow of £16.9 million (2004: £11.9 million, 2003: £28.3 million) in respect of the various<br />
restructuring programmes.<br />
ii) Litigation settlement<br />
An action was filed in the US against The <strong>BOC</strong> Group Cash Balance Retirement Plan (the Plan). It was alleged that the Plan improperly calculated lump<br />
sum distributions from the Plan in violation of the Employee Retirement Income Security Act. In November 2003, the parties reached an agreement<br />
to settle at US$69 million (£43.2 million).The settlement was approved by the court in March 2004.The full amount was provided in 2003 as an<br />
exceptional item.The settlement is being paid out of Plan assets.<br />
<strong>2005</strong> 2004 2003<br />
£ million £ million £ million<br />
Credited/(charged) after operating profit<br />
Profit on disposal of businesses – continuing operations 98.1 – –<br />
Loss on disposal of business – continuing operations – (79.5) –<br />
Profit on disposal of fixed assets – continuing operations 10.5 4.9 –<br />
Total non-operating exceptional items 108.6 (74.6) –<br />
iii) Disposal of businesses<br />
The sale of Afrox Healthcare Limited in South Africa was completed on 22 March <strong>2005</strong>.African Oxygen Limited, <strong>BOC</strong>’s subsidiary in South Africa, retains<br />
a significant interest in the hospitals business through a 20 per cent holding in the new company.The gain on disposal was £84.9 million.<br />
The sale of the packaged gas business in the US was completed on 30 July 2004.The loss on disposal of £79.5 million in 2004 included the write-off<br />
of the assets associated with the business, severance <strong>and</strong> other disposal costs. It also included a goodwill write-off of £19.9 million, of which £15.3 million<br />
had been written off to reserves in the years up to, <strong>and</strong> including, 1998 in accordance with prevailing UK GAAP at that time. Part of the consideration was<br />
payable subject to certain conditions <strong>and</strong> accordingly was not recognised in 2004.This remaining consideration was received in November <strong>2005</strong> <strong>and</strong> has<br />
been recognised in <strong>2005</strong> as an exceptional item.<br />
iv) Profit on disposal of fixed assets<br />
The sale of an investment in the US in <strong>2005</strong> resulted in a profit of £10.5 million, which has been accounted for as an exceptional item.The sale of property<br />
in the UK in 2004 resulted in a profit of £4.9 million, which was accounted for as an exceptional item.<br />
c) Fees to auditors<br />
<strong>2005</strong> 2004 2003<br />
£ million £ million £ million<br />
Audit fees (Parent £0.3 million, 2004: £0.4 million, 2003: £0.4 million) 2.2 2.5 2.0<br />
Non-audit fees<br />
Tax services – advisory 1.0 0.7 0.8<br />
– compliance 0.2 0.4 0.8<br />
Audit related services 1 1.9 0.9 0.5<br />
Other services (expatriate administration services) 2 1.1 1.1 1.4<br />
Total non-audit fees 4.2 3.1 3.5<br />
Total fees paid to auditors 6.4 5.6 5.5<br />
1. Audit related services include advice associated with the implementation of Section 404 of the US Sarbanes-Oxley Act 2002 <strong>and</strong> International Financial <strong>Report</strong>ing St<strong>and</strong>ards.These services are<br />
treated as non-audit services in <strong>2005</strong>.<br />
2. The expatriate administration contract was signed in June 2001 for a five year period following a competitive tender process.<br />
3. The audit fees for the Afrox hospitals business are £0.4 million for <strong>2005</strong>.These fees are not included in the above figures for <strong>2005</strong> following the disposal by <strong>BOC</strong>’s South African subsidiary of its<br />
majority shareholding in Afrox Healthcare Limited in March <strong>2005</strong>.<br />
<strong>BOC</strong> operates a number of policies designed to ensure auditor independence <strong>and</strong> objectivity.The audit committee is responsible for overseeing<br />
implementation of these policies including the review of all expenditure related to non-audit services.The audit committee, by delegation to the chairman<br />
of the audit committee, approves in advance any non-audit services <strong>and</strong> has approved a policy that prevents the use of the auditor for any services that<br />
could threaten the independence or objectivity of the audit.